Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 403 results for "Victoza"

Novo Nordisk A/S Release: Victoza (liraglutide [rDNA origin] injection) Provided Superior Hba1c Reductions In Adults With Type 2 Diabetes Compared To Continued Sitagliptin Treatment

Human medicines European public assessment report (EPAR): Vi...

This is a summary of the European public assessment report (EPAR) for Victoza. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ... European Medicines Agency, 1 month ago

5 images for Victoza

Pharma Letter, 3 weeks ago, 1 month ago
Endocrinology Advisor, 1 month ago, 1 month ago
BioSpace, 1 month ago

Pending EC decision: Victoza, liraglutide, Opinion date: 28-Apr-2016

the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Victoza. The marketing authorisation holder for this medicinal product ...
 European Medicines Agency3 weeks ago News and press releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 April 2016  European Medicines Agency3 weeks ago

FDA staffers air concerns over Novo's Victoza-Tresiba combo

Novo Nordisk is counting on its marriage of Tresiba and Victoza--already approved in the EU as Xultophy--to keep ahead of competition from Sanofi on its way to the blockbuster strata. But before it can get going in the U.S., FDA advisers have ...
 FiercePharma4 days ago Novo Nordisk Receives Positive CHMP Opinion for Extended Victoza Indication  FirstWord Pharma3 weeks ago Victoza to Fuel Growth for Novo Nordisk  Yahoo! Finance UK and Ireland1 month ago Novo says Victoza bests MSD's Januvia at lowering blood sugar  Pharmafile1 month ago

Novo Nordisk A/S 1Q 2016 -- Forecast

=== Sales: -NovoRapid/ 1st Quarter -Total -Victoza -Levemir NovoLog AVERAGE 26,975 4,589 4,400 4,998 Prev. Year 25,200 3,957 ...
 Morningstar.com3 weeks ago Novo Nordisk: Earnings Are In, When Will This Stock Lift Off?  Seeking Alpha3 weeks ago Novo Nordisk cuts annual guidance due to currency effects  FirstWord Pharma3 weeks ago NOVO NORDISK A/S : Trims Guidance on Currency Rates  4 Traders3 weeks ago

New and Generic Drug Approvals: Victoza

Drug Name(s) VICTOZA FDA Application No. (NDA) 022341 Active Ingredient(s) LIRAGLUTIDE RECOMBINANT Company NOVO NORDISK INC Original Approval or Tentative Approval Date January 25, 2010 Chemical Type 1New molecular entity (NME) Review ...
 U.S. Food and Drug Administration4 weeks ago U.S. FDA panel recommends approval of Novo Nordisk diabetes drug  Yahoo! News12 hours ago FDA panel recommends approval of Novo Nordisk diabetes drug  SRN News52 minutes ago RPT-UPDATE 2-U.S. FDA panel recommends approval of Novo Nordisk diabetes drug  Reuters UK3 hours ago

Victoza (liraglutide) Injection, for Subcutaneous Use

Label Changes for: April 2016 Changes have been made to the ADVERSE REACTIONS sections of the safety label. Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) April 2016 ADVERSE ...
 Drugs.com1 week ago

Now Novo Says Semaglutide Cuts CV Risk: SUSTAIN-6 Top-line Data

Just over a month after Novo Nordisk announced positive top-line results for liraglutide (Victoza, Novo Nordisk), showing that it significantly reduced the risk of major adverse cardiovascular events in the LEADER Liraglutide Effect and Action in ...
 RxList3 weeks ago Novo Nordisk reports positive results for semaglutide and Victoza at ENDO  Pharma Letter1 month ago NOVO NORDISK A/S : Victoza┬« Significantly Reduced the Risk of Major Adverse Cardiovascular Events in the LEADER Trial  4 Traders2 months ago Novo Nordisk Q1 top line up 8%; EPS up 23%; CF Ops up 82%  Seeking Alpha3 weeks ago
European Pharmaceutical Review

New data for semaglutide and liraglutide presented at ENDO 2016

Novo Nordisk has presented new data for semaglutide and Victoza (liraglutide) at the Endocrine Society's 98th Annual Meeting and Expo (ENDO 2016) in Boston, MA, US. Findings from the first Phase IIIa clinical trial for semaglutide, demonstrated ...
 European Pharmaceutical Review1 month ago
Monthly Prescribing Reference

Drug Switch Leads to Superior HbA1c Reduction in Sitagliptin vs. Victoza Study

Share this article: Victoza is a glucagon-like peptide-1 (GLP-1) receptor agonist Switching from sitagliptin to Victoza (liraglutide [rDNA origin]; Novo Nordisk), in combination with metformin, showed superior HbA1c reductions vs. continuing ...
 Monthly Prescribing Reference1 month ago

FDA advisors offer unanimous backing for Novo's diabetes combo

An FDA advisory committee handed Novo Nordisk a rousing endorsement for its diabetes combo IDegLira, voting 16 to 0 on Tuesday to back the company's marketing application. The vote came after FDA insiders raised a number of objections to the ...
 FierceBiotech8 hours ago FDA advisory committee supports insulin degludec/liraglutide for type 2 diabetes  Healio9 hours ago IDegLira receives unanimous 16-0 vote in favor of approval from FDA Advisory Committee  PredictWallStreet9 hours ago FDA advisory panel unanimously backs approval of Novo Nordisk's diabetes drug IDegLira  FirstWord Pharma10 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Victoza
Get updated on latest news & your favorite topics right in your inbox!
More     Less